Key facts
- This page summarizes Flagship Pioneering, LLC's Form 4 filing for Omega Therapeutics, Inc. (OMGAQ).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 27 Feb 2023, 16:20.
Flagship Pioneering, LLC - 27 Feb 2023 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- OMGAQ
- Reported as of
- 27 Feb 2023
- Net transaction value
- +$19,208,732
- SEC form
- 4
- Accepted by SEC
- 27 Feb 2023, 16:20:26 UTC
- Prior SEC filing
- 17 Oct 2022
- Next SEC filing
- 15 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- Flagship Pioneering, Inc., By: /s/ Noubar B. Afeyan, Ph.D., Chief Executive Officer
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Flagship Pioneering, LLC filed Form 4 for Omega Therapeutics, Inc. (OMGAQ) on 27 Feb 2023.
Change
- Previous filing in this sequence was filed on 17 Oct 2022.
- Current net transaction value: +$19,208,732.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OMGA
transaction
Common Stock
Purchase
- Transaction value
- $11,525,239
- Shares
- +1,993,986
- Change %
- +36%
- Price
- $5.78
- Shares after
- 7,508,693
- Date
- 27 Feb 2023
- Ownership
- By Flagship Pioneering Special Opportunities Fund II, L.P.
- Footnotes
- F1, F2
OMGA
transaction
Common Stock
Purchase
- Transaction value
- $7,683,493
- Shares
- +1,329,324
- Change %
- Price
- $5.78
- Shares after
- 1,329,324
- Date
- 27 Feb 2023
- Ownership
- By Flagship Pioneering Fund VII, L.P.
- Footnotes
- F1, F3
OMGA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,088,470
- Date
- 27 Feb 2023
- Ownership
- By Flagship V VentureLabs Rx Fund, L.P.
- Footnotes
- F4
OMGA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,896,386
- Date
- 27 Feb 2023
- Ownership
- By Flagship Ventures Fund V, L.P.
- Footnotes
- F5
OMGA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 8,617,413
- Date
- 27 Feb 2023
- Ownership
- By Flagship Pioneering Fund VI, L.P.
- Footnotes
- F6
OMGA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 970,588
- Date
- 27 Feb 2023
- Ownership
- By Nutritional Health LTP Fund, L.P.
- Footnotes
- F7
OMGA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,617,646
- Date
- 27 Feb 2023
- Ownership
- By FPN, L.P.
- Footnotes
- F8
OMGA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,197,059
- Date
- 27 Feb 2023
- Ownership
- By Flagship VentureLabs V, LLC
- Footnotes
- F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
On February 27, 2023, Flagship Pioneering Special Opportunities Fund II, L.P. ("Flagship Opportunities Fund II") and Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") purchased 1,993,986 shares and 1,329,324 shares, respectively, of the Issuer's Common Stock in a registered direct offering at a price of $5.78 per share pursuant to a Securities Purchase Agreement dated February 22, 2023.
Footnote F2
Represents shares held directly by Flagship Opportunities Fund II. Flagship Pioneering Special Opportunities Fund II General Partner LLC ("Flagship Opportunities Fund II GP") is the general partner of Flagship Opportunities Fund II. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Flagship Opportunities Fund II GP. Noubar B. Afeyan, Ph.D. is the Chief Executive Officer, sole shareholder and director of Flagship Pioneering. Each of the reporting persons except Flagship Opportunities Fund II disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
Footnote F3
Represents shares held directly by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering is the manager of Flagship Fund VII GP. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
Footnote F4
Represents shares held directly by Flagship V VentureLabs Rx Fund, L.P. ("Flagship Fund V Rx"). Flagship Ventures Fund V General Partner LLC ("Flagship V GP") is the general partner of Flagship Fund V Rx. Dr. Afeyan is the sole manager of Flagship V GP. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
Footnote F5
Represents shares held directly by Flagship Ventures Fund V, L.P. ("Flagship Fund V"). Flagship V GP is the general partner of Flagship Fund V. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
Footnote F6
Represents shares held directly by Flagship Pioneering Fund VI, L.P. ("Flagship Fund VI"). Flagship Pioneering Fund VI General Partner LLC ("Flagship Fund VI GP") is the general partner of Flagship Fund VI. Flagship Pioneering is the manager of Flagship Fund VI GP. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
Footnote F7
Represents shares held directly by Nutritional Health LTP Fund, L.P. ("Nutritional LTP"). Nutritional Health LTP Fund General Partner LLC ("Nutritional LTP GP") is the general partner of Nutritional LTP. Flagship Pioneering is the manager of Nutritional LTP GP. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
Footnote F8
Represents shares held directly by FPN, L.P. ("FPN Fund"). FPN General Partner LLC ("FPN GP") is the general partner of FPN Fund. Flagship Pioneering is the manager of FPN GP. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
Footnote F9
Represents shares held directly by Flagship VentureLabs V, LLC ("VentureLabs V"). VentureLabs V Manager LLC ("VentureLabs V Manager") is the manager of VentureLabs V. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of VentureLabs V Manager. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.